Table 1.
Demographic Characteristics of Study Patients
| Variable | All Patients, n = 75 | Malignant Pericardial Effusion, n = 19 | Nonmalignant Pericardial Effusion, n = 30 | Pericardial Fluid, n = 26 | P Valuea |
| M/F | 45/30 | 9/10 | 15/15 | 21/5b,c, b, b,c, c | <0.05 |
| Age, y | 64.1 ± 10.6 | 60.1 ± 8.9 | 61.1 ± 11.1 | 70.6 ± 8.3b,c, b, b,c, c | <0.05 |
| CAD, n (%) | 27 (36) | 0 | 1 (3) | 26 (100)b,c, b, b,c, c | <0.05 |
| Creatinine, mg/dL | 1.06 ± 0.77 | 0.82 ± 0.22 | 1.05 ± 1.01 | 1.29 ± 0.6b,c, b, b,c, c | <0.05 |
| Leukocytes, g/L | 9.55 ± 7.46 | 12.66 ± 13.11c | 8.76 ± 3.1 | 7.61 ± 1.98b | <0.05 |
| Protein, g/dL | 64.75 ± 15.03 | 65.22 ± 8.76 | 60.17 ± 19.55 | 72.06 ± 6.63 | NS |
| CRP, mg/L | 48.56 ± 86.97 | 81.59 ± 76.77c | 54.39 ± 106.61 | 3.25 ± 4.47b | <0.05 |
Abbreviations: ANOVA, analysis of variance; CAD, coronary artery disease; CRP, C‐reactive protein; F, female; M, male; mPE, malignant pericardial effusion; nPE, nonmalignant pericardial effusion; NS, not significant. Values are mean ± SD, or no. of patients (%).
a
ANOVA/χ 2 test.
b,c, b
P < 0.05 vs mPE.
b,c, c
P < 0.05 vs nPE.